Bengaluru-based PinkBlue raises over Rs 5 Cr from Orios Venture Partners

Chakr

Clinical supplies provider PinkBlue has raised Rs 5.1 crore in Pre-Series A round from Orios Venture Partners. The debt funding also saw the participation of other investors, including Anupam Mittal, Sakate Khaitan and HNIs.

The company had raised Rs 1.5 crore in 2016 in a seed round funding from TermSheet.io, Anirudh Rastogi, Abhishek Jain, and others. The e-commerce platform has so far raised Rs 6.6 crore. Meanwhile, the company has not answered the queries sent by Entrackr till the publication of the report.

Founded in 2014 by Valliappan Kumarappan, Varun Singh and Arun Sriram, PinkBlue supplies dental products, materials, instruments and equipments to healthcare institutions online.

The platform, which is considered to be the first player in the dental materials supply market, claims to bring transparency in pricing, efficiency on delivery and convenience of online ordering of multiple brands at one marketplace.

The Bengaluru-based company also provides a SaaS-based intuitive materials management platform to enhance the supply chain management capabilities of both healthcare institutions and manufacturers by creating visibility over a complex supply chain.

The company claims to have reached over 80,000 dentists with a wide catalogue of 35,000 dental products.


Also Read: Hyderabad-based eKincare secures $1.5 million Series A round led by Ventureast


The online e-commerce dental supplier competes with other healthcare platforms like NetMeds, MedGenome, 1mg, and Medibox, among others.

Currently, the overall healthcare market in India is estimated to be worth around $100 billion, and the online market is estimated to grow to over $42 billion in the coming years. But not many core healthcare players are entering the analytics part exclusively; they usually provide overall healthcare services like booking appointments and facilitating video chats.

The funding news was first reported by paper.vc.

Comments

LEAVE A REPLY

Please enter your comment!
Please enter your name here